In semiconductor dealmaking, the price is the message. Onsemi’s revised agreement to acquire Synaptics for $123 per share in cash gives merger-arbitrage traders a clearly defined reference point and puts the market’s attention squarely on the distance between that consideration and the trading price of $SYNA.
For Onsemi shareholders, the other message is strategic: the companies say the revised transaction is expected to deliver immediate earnings-per-share accretion for $ON. That claim may support the buyer’s investment case—but it also raises the bar for how investors assess Onsemi’s share-price reaction once the market digests the terms.
On October 1, Onsemi and Synaptics jointly announced a Revised Merger Agreement under which Onsemi will acquire Synaptics for $123 per share in cash. The announcement was also reported by GlobeNewswire, while Seeking Alpha reported the revised $123 offer.
Why the $123 figure matters to SYNA arbitrage
A cash acquisition creates a straightforward framework for merger-arbitrage analysis. The revised offer price is $123 per Synaptics share. If $SYNA trades below that level, the difference represents the market’s implied spread between the current trading price and the stated cash consideration. If the stock trades near $123, the spread is narrower; if it trades farther below the offer, the market is assigning a wider gap.
That spread is not a promise of completion or a guaranteed outcome. It is the market’s way of pricing uncertainty around the path from announced agreement to cash consideration. The supplied deal details do not identify closing conditions, regulatory milestones, or other transaction mechanics, so traders are limited to the terms that have been reported: a revised merger agreement and $123 in cash per share.
The practical point is simple. The revised consideration gives $SYNA traders a new anchor. The stock may trade near, but not necessarily at, the $123 offer price as the market weighs the announced terms. The size of that difference—and how quickly it changes—would be the central short-term signal for merger-arbitrage positioning.
Onsemi’s stock faces a different test
For $ON, the headline is not merely that the company is buying Synaptics. It is that the companies describe the revised deal as immediately EPS accretive for Onsemi shareholders. That assertion could help frame the acquisition as financially additive from the outset rather than purely strategic.
Still, the share-price reaction may depend on how investors interpret the claim. A favorable response could indicate that the market is giving weight to the expected immediate accretion. A weaker response could suggest that shareholders are focusing more cautiously on the acquisition’s execution or on the implications of issuing cash for the transaction. The assignment provides no market price or measured reaction for $ON, so any assessment must remain prospective rather than definitive.
A sharper signal for semiconductor M&A
The sweetened acquisition also carries broader significance for consolidation across the chip and sensor sector. Onsemi’s move to revise the offer for Synaptics suggests that strategic transactions can remain active even when the terms require adjustment. That makes this deal a useful case study in how buyers and sellers negotiate value—and how markets separate the target’s cash consideration from the acquirer’s earnings narrative.
The bottom line: $SYNA now has a clearly reported $123 cash reference price, while $ON must persuade shareholders that immediate EPS accretion justifies the revised transaction. Until more deal-specific information is reported, those are the two signals traders can analyze without reaching beyond the announced terms.
Bull/Bear Verdict
Bull Case: The $123-per-share cash consideration may give $SYNA a firm valuation anchor, while the companies’ statement that the revised deal is immediately EPS accretive could support the case for $ON.
Bear Case: $SYNA may continue to trade below the $123 offer price as the market prices uncertainty around the announced merger, while $ON could face skepticism if shareholders give less weight to the claim of immediate EPS accretion.